Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Orthofix Medical (OFIX) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Orthofix Medical (OFIX) over the last 16 years, with Q3 2025 value amounting to $571000.0.

  • Orthofix Medical's Other Non Operating Income rose 12258.7% to $571000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year increase of 22726.18%. This contributed to the annual value of -$9.6 million for FY2024, which is 50879.19% down from last year.
  • Latest data reveals that Orthofix Medical reported Other Non Operating Income of $571000.0 as of Q3 2025, which was up 12258.7% from $5.7 million recorded in Q2 2025.
  • Orthofix Medical's Other Non Operating Income's 5-year high stood at $7.5 million during Q4 2021, with a 5-year trough of -$4.2 million in Q4 2022.
  • Over the past 5 years, Orthofix Medical's median Other Non Operating Income value was -$269000.0 (recorded in 2023), while the average stood at -$343052.6.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first tumbled by 279349.59% in 2024, then surged by 32828.69% in 2025.
  • Over the past 5 years, Orthofix Medical's Other Non Operating Income (Quarter) stood at $7.5 million in 2021, then tumbled by 155.87% to -$4.2 million in 2022, then surged by 102.93% to $123000.0 in 2023, then tumbled by 2793.5% to -$3.3 million in 2024, then surged by 117.24% to $571000.0 in 2025.
  • Its last three reported values are $571000.0 in Q3 2025, $5.7 million for Q2 2025, and $1.2 million during Q1 2025.